APO Research
Talk to an analyst

APO RESEARCH · REPORT

Daratumumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Daratumumab Market Analysis and Forecast 2026-2032

23 December 2025195 pages

Choose your research edition.

Industry ResearchDaratumumab Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Daratumumab Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Daratumumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daratumumab Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Daratumumab Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Daratumumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Daratumumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Daratumumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Daratumumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Daratumumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Daratumumab include Johnson＆Johnson. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Daratumumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Daratumumab, also provides the sales of main regions and countries. Of the upcoming market potential for Daratumumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Daratumumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Daratumumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Daratumumab sales, projected growth trends, production technology, application and end-user industry.

Daratumumab Segment by Company

Johnson＆Johnson

Daratumumab Segment by Type

100mg Injection

400mg Injection

Daratumumab Segment by Application

Multiple Myeloma

Follicular Lymphoma

Diffuse Large B Cell Lymphoma

Mantle Cell Lymphoma

Others

Daratumumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daratumumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daratumumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daratumumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Daratumumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Daratumumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Daratumumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Daratumumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg Injection Major Manufacturers Table 3. 400mg Injection Major Manufacturers Table 4. Global Daratumumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Multiple Myeloma Major Manufacturers Table 6. Follicular Lymphoma Major Manufacturers Table 7. Diffuse Large B Cell Lymphoma Major Manufacturers Table 8. Mantle Cell Lymphoma Major Manufacturers Table 9. Others Major Manufacturers Table 10. Daratumumab Industry Trends Table 11. Daratumumab Industry Drivers Table 12. Daratumumab Industry Opportunities and Challenges Table 13. Daratumumab Industry Restraints Table 14. Global Daratumumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Daratumumab Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Daratumumab Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Daratumumab Revenue Market Share by Region (2021-2026) Table 18. Global Daratumumab Revenue Market Share by Region (2027-2032) Table 19. Global Daratumumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Daratumumab Sales by Region (2021-2026) & (k units) Table 21. Global Daratumumab Sales by Region (2027-2032) & (k units) Table 22. Global Daratumumab Sales Market Share by Region (2021-2026) Table 23. Global Daratumumab Sales Market Share by Region (2027-2032) Table 24. Global Daratumumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Daratumumab Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Daratumumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Daratumumab Sales Market Share by Manufacturers (2021-2026) Table 28. Global Daratumumab Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Daratumumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Daratumumab Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Daratumumab Manufacturers, Product Type & Application Table 32. Global Daratumumab Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Daratumumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Daratumumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Daratumumab Revenue Market Share by Type (2021-2026) Table 39. Global Daratumumab Revenue Market Share by Type (2027-2032) Table 40. Global Daratumumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Daratumumab Sales by Type (2021-2026) & (k units) Table 42. Global Daratumumab Sales by Type (2027-2032) & (k units) Table 43. Global Daratumumab Sales Market Share by Type (2021-2026) Table 44. Global Daratumumab Sales Market Share by Type (2027-2032) Table 45. Global Daratumumab Price by Type (2021-2026) & (US$/unit) Table 46. Global Daratumumab Price by Type (2027-2032) & (US$/unit) Table 47. Global Daratumumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Daratumumab Revenue Market Share by Application (2021-2026) Table 51. Global Daratumumab Revenue Market Share by Application (2027-2032) Table 52. Global Daratumumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Daratumumab Sales by Application (2021-2026) & (k units) Table 54. Global Daratumumab Sales by Application (2027-2032) & (k units) Table 55. Global Daratumumab Sales Market Share by Application (2021-2026) Table 56. Global Daratumumab Sales Market Share by Application (2027-2032) Table 57. Global Daratumumab Price by Application (2021-2026) & (US$/unit) Table 58. Global Daratumumab Price by Application (2027-2032) & (US$/unit) Table 59. Johnson＆Johnson Company Information Table 60. Johnson＆Johnson Business Overview Table 61. Johnson＆Johnson Daratumumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Johnson＆Johnson Daratumumab Product Portfolio Table 63. Johnson＆Johnson Recent Development Table 64. North America Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Daratumumab Sales by Type (2021-2026) & (k units) Table 67. North America Daratumumab Sales by Type (2027-2032) & (k units) Table 68. North America Daratumumab Sales Price by Type (2021-2026) & (US$/unit) Table 69. North America Daratumumab Sales Price by Type (2027-2032) & (US$/unit) Table 70. North America Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 71. North America Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 72. North America Daratumumab Sales by Application (2021-2026) & (k units) Table 73. North America Daratumumab Sales by Application (2027-2032) & (k units) Table 74. North America Daratumumab Sales Price by Application (2021-2026) & (US$/unit) Table 75. North America Daratumumab Sales Price by Application (2027-2032) & (US$/unit) Table 76. North America Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Daratumumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 78. North America Daratumumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 79. North America Daratumumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 80. North America Daratumumab Sales by Country (2021-2026) & (k units) Table 81. North America Daratumumab Sales by Country (2027-2032) & (k units) Table 82. North America Daratumumab Sales Price by Country (2021-2026) & (US$/unit) Table 83. North America Daratumumab Sales Price by Country (2027-2032) & (US$/unit) Table 84. United States Daratumumab Revenue (2021-2032) & (US$ Million) Table 85. Canada Daratumumab Revenue (2021-2032) & (US$ Million) Table 86. Mexico Daratumumab Revenue (2021-2032) & (US$ Million) Table 87. Europe Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Daratumumab Sales by Type (2021-2026) & (k units) Table 90. Europe Daratumumab Sales by Type (2027-2032) & (k units) Table 91. Europe Daratumumab Sales Price by Type (2021-2026) & (US$/unit) Table 92. Europe Daratumumab Sales Price by Type (2027-2032) & (US$/unit) Table 93. Europe Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Daratumumab Sales by Application (2021-2026) & (k units) Table 96. Europe Daratumumab Sales by Application (2027-2032) & (k units) Table 97. Europe Daratumumab Sales Price by Application (2021-2026) & (US$/unit) Table 98. Europe Daratumumab Sales Price by Application (2027-2032) & (US$/unit) Table 99. Europe Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Daratumumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. Europe Daratumumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. Europe Daratumumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. Europe Daratumumab Sales by Country (2021-2026) & (k units) Table 104. Europe Daratumumab Sales by Country (2027-2032) & (k units) Table 105. Europe Daratumumab Sales Price by Country (2021-2026) & (US$/unit) Table 106. Europe Daratumumab Sales Price by Country (2027-2032) & (US$/unit) Table 107. Germany Daratumumab Revenue (2021-2032) & (US$ Million) Table 108. France Daratumumab Revenue (2021-2032) & (US$ Million) Table 109. U.K. Daratumumab Revenue (2021-2032) & (US$ Million) Table 110. Italy Daratumumab Revenue (2021-2032) & (US$ Million) Table 111. Russia Daratumumab Revenue (2021-2032) & (US$ Million) Table 112. Spain Daratumumab Revenue (2021-2032) & (US$ Million) Table 113. Netherlands Daratumumab Revenue (2021-2032) & (US$ Million) Table 114. Switzerland Daratumumab Revenue (2021-2032) & (US$ Million) Table 115. Sweden Daratumumab Revenue (2021-2032) & (US$ Million) Table 116. Poland Daratumumab Revenue (2021-2032) & (US$ Million) Table 117. China Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 118. China Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 119. China Daratumumab Sales by Type (2021-2026) & (k units) Table 120. China Daratumumab Sales by Type (2027-2032) & (k units) Table 121. China Daratumumab Sales Price by Type (2021-2026) & (US$/unit) Table 122. China Daratumumab Sales Price by Type (2027-2032) & (US$/unit) Table 123. China Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 124. China Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 125. China Daratumumab Sales by Application (2021-2026) & (k units) Table 126. China Daratumumab Sales by Application (2027-2032) & (k units) Table 127. China Daratumumab Sales Price by Application (2021-2026) & (US$/unit) Table 128. China Daratumumab Sales Price by Application (2027-2032) & (US$/unit) Table 129. Asia Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Daratumumab Sales by Type (2021-2026) & (k units) Table 132. Asia Daratumumab Sales by Type (2027-2032) & (k units) Table 133. Asia Daratumumab Sales Price by Type (2021-2026) & (US$/unit) Table 134. Asia Daratumumab Sales Price by Type (2027-2032) & (US$/unit) Table 135. Asia Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Daratumumab Sales by Application (2021-2026) & (k units) Table 138. Asia Daratumumab Sales by Application (2027-2032) & (k units) Table 139. Asia Daratumumab Sales Price by Application (2021-2026) & (US$/unit) Table 140. Asia Daratumumab Sales Price by Application (2027-2032) & (US$/unit) Table 141. Asia Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Daratumumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Asia Daratumumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Asia Daratumumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 145. Asia Daratumumab Sales by Country (2021-2026) & (k units) Table 146. Asia Daratumumab Sales by Country (2027-2032) & (k units) Table 147. Asia Daratumumab Sales Price by Country (2021-2026) & (US$/unit) Table 148. Asia Daratumumab Sales Price by Country (2027-2032) & (US$/unit) Table 149. Japan Daratumumab Revenue (2021-2032) & (US$ Million) Table 150. South Korea Daratumumab Revenue (2021-2032) & (US$ Million) Table 151. India Daratumumab Revenue (2021-2032) & (US$ Million) Table 152. Australia Daratumumab Revenue (2021-2032) & (US$ Million) Table 153. Taiwan Daratumumab Revenue (2021-2032) & (US$ Million) Table 154. Southeast Asia Daratumumab Revenue (2021-2032) & (US$ Million) Table 155. SAMEA Daratumumab Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Daratumumab Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Daratumumab Sales by Type (2021-2026) & (k units) Table 158. SAMEA Daratumumab Sales by Type (2027-2032) & (k units) Table 159. SAMEA Daratumumab Sales Price by Type (2021-2026) & (US$/unit) Table 160. SAMEA Daratumumab Sales Price by Type (2027-2032) & (US$/unit) Table 161. SAMEA Daratumumab Revenue by Application (2021-2026) & (US$ Million) Table 162. SAMEA Daratumumab Revenue by Application (2027-2032) & (US$ Million) Table 163. SAMEA Daratumumab Sales by Application (2021-2026) & (k units) Table 164. SAMEA Daratumumab Sales by Application (2027-2032) & (k units) Table 165. SAMEA Daratumumab Sales Price by Application (2021-2026) & (US$/unit) Table 166. SAMEA Daratumumab Sales Price by Application (2027-2032) & (US$/unit) Table 167. SAMEA Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. SAMEA Daratumumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. SAMEA Daratumumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. SAMEA Daratumumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. SAMEA Daratumumab Sales by Country (2021-2026) & (k units) Table 172. SAMEA Daratumumab Sales by Country (2027-2032) & (k units) Table 173. SAMEA Daratumumab Sales Price by Country (2021-2026) & (US$/unit) Table 174. SAMEA Daratumumab Sales Price by Country (2027-2032) & (US$/unit) Table 175. Brazil Daratumumab Revenue (2021-2032) & (US$ Million) Table 176. Argentina Daratumumab Revenue (2021-2032) & (US$ Million) Table 177. Chile Daratumumab Revenue (2021-2032) & (US$ Million) Table 178. Colombia Daratumumab Revenue (2021-2032) & (US$ Million) Table 179. Peru Daratumumab Revenue (2021-2032) & (US$ Million) Table 180. Saudi Arabia Daratumumab Revenue (2021-2032) & (US$ Million) Table 181. Israel Daratumumab Revenue (2021-2032) & (US$ Million) Table 182. UAE Daratumumab Revenue (2021-2032) & (US$ Million) Table 183. Turkey Daratumumab Revenue (2021-2032) & (US$ Million) Table 184. Iran Daratumumab Revenue (2021-2032) & (US$ Million) Table 185. Egypt Daratumumab Revenue (2021-2032) & (US$ Million) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Daratumumab Distributors List Table 189. Daratumumab Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Daratumumab Image Figure 2. Global Daratumumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daratumumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg Injection Image Figure 5. 400mg Injection Image Figure 6. Global Daratumumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Daratumumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Multiple Myeloma Image Figure 9. Follicular Lymphoma Image Figure 10. Diffuse Large B Cell Lymphoma Image Figure 11. Mantle Cell Lymphoma Image Figure 12. Others Image Figure 13. Global Daratumumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Daratumumab Revenue (2021-2032) & (US$ Million) Figure 15. Global Daratumumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Daratumumab Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Daratumumab Revenue Market Share by Region (2021-2032) Figure 18. Global Daratumumab Sales (2021-2032) & (k units) Figure 19. Global Daratumumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Daratumumab Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Daratumumab Sales YoY (2021-2032) & (k units) Figure 22. Europe Daratumumab Sales YoY (2021-2032) & (k units) Figure 23. China Daratumumab Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Daratumumab Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Daratumumab Sales YoY (2021-2032) & (k units) Figure 26. Global Daratumumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Daratumumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Daratumumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Daratumumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Daratumumab Revenue Market Share by Type (2021-2032) Figure 32. Global Daratumumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Daratumumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Daratumumab Sales Market Share by Type (2021-2032) Figure 35. Global Daratumumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Daratumumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Daratumumab Revenue Market Share by Application (2021-2032) Figure 38. Global Daratumumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Daratumumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Daratumumab Sales Market Share by Application (2021-2032) Figure 41. North America Daratumumab Revenue Share by Type (2021-2032) Figure 42. North America Daratumumab Sales Share by Type (2021-2032) Figure 43. North America Daratumumab Revenue Share by Application (2021-2032) Figure 44. North America Daratumumab Sales Share by Application (2021-2032) Figure 45. North America Daratumumab Revenue Share by Country (2021-2032) Figure 46. North America Daratumumab Sales Share by Country (2021-2032) Figure 47. Europe Daratumumab Revenue Share by Type (2021-2032) Figure 48. Europe Daratumumab Sales Share by Type (2021-2032) Figure 49. Europe Daratumumab Revenue Share by Application (2021-2032) Figure 50. Europe Daratumumab Sales Share by Application (2021-2032) Figure 51. Europe Daratumumab Revenue Share by Country (2021-2032) Figure 52. Europe Daratumumab Sales Share by Country (2021-2032) Figure 53. China Daratumumab Revenue Share by Type (2021-2032) Figure 54. China Daratumumab Sales Share by Type (2021-2032) Figure 55. China Daratumumab Revenue Share by Application (2021-2032) Figure 56. China Daratumumab Sales Share by Application (2021-2032) Figure 57. Asia Daratumumab Revenue Share by Type (2021-2032) Figure 58. Asia Daratumumab Sales Share by Type (2021-2032) Figure 59. Asia Daratumumab Revenue Share by Application (2021-2032) Figure 60. Asia Daratumumab Sales Share by Application (2021-2032) Figure 61. Asia Daratumumab Revenue Share by Country (2021-2032) Figure 62. Asia Daratumumab Sales Share by Country (2021-2032) Figure 63. SAMEA Daratumumab Revenue Share by Type (2021-2032) Figure 64. SAMEA Daratumumab Sales Share by Type (2021-2032) Figure 65. SAMEA Daratumumab Revenue Share by Application (2021-2032) Figure 66. SAMEA Daratumumab Sales Share by Application (2021-2032) Figure 67. SAMEA Daratumumab Revenue Share by Country (2021-2032) Figure 68. SAMEA Daratumumab Sales Share by Country (2021-2032) Figure 69. Daratumumab Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Daratumumab Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg Injection
  • 400mg Injection
Applications
  • Multiple Myeloma
  • Follicular Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Mantle Cell Lymphoma
  • Others
Companies covered
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Daratumumab Market by Type
  3. 1.2.1 Global Daratumumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg Injection
  5. 1.2.3 400mg Injection
  6. 1.3 Daratumumab Market by Application
  7. 1.3.1 Global Daratumumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Multiple Myeloma
  9. 1.3.3 Follicular Lymphoma
  10. 1.3.4 Diffuse Large B Cell Lymphoma
  11. 1.3.5 Mantle Cell Lymphoma
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Daratumumab Market Dynamics
  1. 2.1 Daratumumab Industry Trends
  2. 2.2 Daratumumab Industry Drivers
  3. 2.3 Daratumumab Industry Opportunities and Challenges
  4. 2.4 Daratumumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Daratumumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Daratumumab Revenue by Region
  3. 3.2.1 Global Daratumumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Daratumumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Daratumumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Daratumumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Daratumumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Daratumumab Sales by Region
  9. 3.4.1 Global Daratumumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Daratumumab Sales by Region (2021-2026)
  11. 3.4.3 Global Daratumumab Sales by Region (2027-2032)
  12. 3.4.4 Global Daratumumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Daratumumab Revenue by Manufacturers
  2. 4.1.1 Global Daratumumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Daratumumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Daratumumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Daratumumab Sales by Manufacturers
  6. 4.2.1 Global Daratumumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Daratumumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Daratumumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Daratumumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Daratumumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Daratumumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Daratumumab Manufacturers, Product Type & Application
  13. 4.7 Global Daratumumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Daratumumab Market CR5 and HHI
  16. 4.8.2 2025 Daratumumab Tier 1, Tier 2, and Tier 3
5 Daratumumab Market by Type
  1. 5.1 Global Daratumumab Revenue by Type
  2. 5.1.1 Global Daratumumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Daratumumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Daratumumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Daratumumab Sales by Type
  6. 5.2.1 Global Daratumumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Daratumumab Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Daratumumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Daratumumab Price by Type
6 Daratumumab Market by Application
  1. 6.1 Global Daratumumab Revenue by Application
  2. 6.1.1 Global Daratumumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Daratumumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Daratumumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Daratumumab Sales by Application
  6. 6.2.1 Global Daratumumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Daratumumab Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Daratumumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Daratumumab Price by Application
7 Company Profiles
  1. 7.1 Johnson＆Johnson
  2. 7.1.1 Johnson＆Johnson Company Information
  3. 7.1.2 Johnson＆Johnson Business Overview
  4. 7.1.3 Johnson＆Johnson Daratumumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson＆Johnson Daratumumab Product Portfolio
  6. 7.1.5 Johnson＆Johnson Recent Developments
8 North America
  1. 8.1 North America Daratumumab Market Size by Type
  2. 8.1.1 North America Daratumumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Daratumumab Sales by Type (2021-2032)
  4. 8.1.3 North America Daratumumab Price by Type (2021-2032)
  5. 8.2 North America Daratumumab Market Size by Application
  6. 8.2.1 North America Daratumumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Daratumumab Sales by Application (2021-2032)
  8. 8.2.3 North America Daratumumab Price by Application (2021-2032)
  9. 8.3 North America Daratumumab Market Size by Country
  10. 8.3.1 North America Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Daratumumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Daratumumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Daratumumab Market Size by Type
  2. 9.1.1 Europe Daratumumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Daratumumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Daratumumab Price by Type (2021-2032)
  5. 9.2 Europe Daratumumab Market Size by Application
  6. 9.2.1 Europe Daratumumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Daratumumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Daratumumab Price by Application (2021-2032)
  9. 9.3 Europe Daratumumab Market Size by Country
  10. 9.3.1 Europe Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Daratumumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Daratumumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Daratumumab Market Size by Type
  2. 10.1.1 China Daratumumab Revenue by Type (2021-2032)
  3. 10.1.2 China Daratumumab Sales by Type (2021-2032)
  4. 10.1.3 China Daratumumab Price by Type (2021-2032)
  5. 10.2 China Daratumumab Market Size by Application
  6. 10.2.1 China Daratumumab Revenue by Application (2021-2032)
  7. 10.2.2 China Daratumumab Sales by Application (2021-2032)
  8. 10.2.3 China Daratumumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Daratumumab Market Size by Type
  2. 11.1.1 Asia Daratumumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Daratumumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Daratumumab Price by Type (2021-2032)
  5. 11.2 Asia Daratumumab Market Size by Application
  6. 11.2.1 Asia Daratumumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Daratumumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Daratumumab Price by Application (2021-2032)
  9. 11.3 Asia Daratumumab Market Size by Country
  10. 11.3.1 Asia Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Daratumumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Daratumumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Daratumumab Market Size by Type
  2. 12.1.1 SAMEA Daratumumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Daratumumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Daratumumab Price by Type (2021-2032)
  5. 12.2 SAMEA Daratumumab Market Size by Application
  6. 12.2.1 SAMEA Daratumumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Daratumumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Daratumumab Price by Application (2021-2032)
  9. 12.3 SAMEA Daratumumab Market Size by Country
  10. 12.3.1 SAMEA Daratumumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Daratumumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Daratumumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Daratumumab Value Chain Analysis
  2. 13.1.1 Daratumumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Daratumumab Production Mode & Process
  6. 13.2 Daratumumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Daratumumab Distributors
  9. 13.2.3 Daratumumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst